Verona Pharma plcVRNA

Market cap

$72.8B

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	188	148	228	272	400
Total cash & short-term investments	188	148	228	272	400
Accounts receivable, net	-	-	-	-	31
Inventories	-	-	-	-	6
Total current assets	203	170	243	290	454
Property, plant and equipment, net	0	0	0	0	1
Total non-current assets	2	17	16	18	21
Total assets	204	187	259	308	474
Accounts payable	0	10	3	3	11
Total current liabilities	14	33	19	9	43
Long-term debt, non-current	5	5	10	48	120
Total non-current liabilities	5	5	10	50	227
Total liabilities	19	39	29	59	270
Common stock and paid-in capital	398	417	570	644	773
Retained earnings	-207	-264	-333	-388	-562
Stockholders' equity	185	148	230	249	205
Total debt	5	5	10	48	120
Net debt	-183	-144	-218	-223	-279
D/E ratio (%)	2.5	3.3	4.2	19.4	58.8
Working capital	-	-	-	-